Updates from The Motley Fool

Latest updates on CASI Pharmaceuticals, Inc from Fool.com.


Stock Performance

CASI vs. S&P 500 | 2 Year Performance
CASI 1-Day Stock Chart
CASI 5-Day Stock Chart
CASI 1-Month Stock Chart
CASI 3-Month Stock Chart
CASI 6-Month Stock Chart
CASI 1-Year Stock Chart
CASI 2-Year Stock Chart
CASI 5-Year Stock Chart
View Interactive CASI Charts
Sponsored by

Key Data Points

Primary metrics and data points about CASI Pharmaceuticals, Inc.
Current Price: $1.25
Prev Close: $1.21
Open: $1.22
Bid: $0.70
Ask: $1.28
Day's Range: $1.22 - $1.25
52wk Range: $0.58 - $2.13
Volume: 3,505
Avg Vol 21,737
Market Cap: $40.42M
P/E (ttm): -6.05
EPS (ttm): -$0.20
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about CASI Pharmaceuticals, Inc.
CAPS Rating 0 out of 5
 
45 Outperform
13 Underperform
CAPS All Stars
 
8 Outperform
7 Underperform

How do you think CASI Pharmaceuticals, Inc will perform against the market?



You pick for CASI Pharmaceuticals, Inc is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for CASI Pharmaceuticals, Inc.

A clinical-stage pharmaceutical company focused on developing multi-mechanism oncology drugs that target disease cells directly and the blood vessels that nourish them.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers